Ruben Mesa, M.D., Chair of Hematology and Medical Oncology at Mayo Clinic in Arizona, discusses the findings of the COMFORT-I, randomized, double-blind, phase III trial of JAK1/2 inhibitor Ruxolitinib vs. placebo in intermediate and high risk myelofibrosis.
Answering Common Patient Questions on Myeloproliferative Neoplasms - Mayo Clinic
Ruben Mesa, M.D., Chair of Hematology and Oncology at Mayo Clinic in Arizona, discusses common patient questions regarding myeloproliferative neoplasms with John Camoriano, M.D., medical oncology consultant at Mayo Clinic.
Survival Data for Patients Younger Than 60 With Primary Myleofibrosis--Mayo Clinic Proceedings
Dr. Ayalew Tefferi, Professor of Hematology and Medicine at Mayo Clinic in Rochester, MN, discusses the findings of the largest ever study with the most mature data currently available of patients with primary myelofibrosis younger than 60 years.
Dr, Ruben Mesa is a Professor of Medicine and Director of the Acute and
Chronic Leukemias Program in the Division of Hematology-Oncology
at the Mayo Clinic in Scottsdale, AZ
Currently, Dr. Mesa has active clinical trial programs for myelofibrosis, Myeloproliferative Neoplasm Disorders, myelodysplastic syndromes and acute myeloid leukemia.
He is co-principal investigator on the international MPN-RC Trials of
Pegasys vs. Hydroxyurea in high risk ET and PV.
The following are presentations by Dr. Mesa explaining the disease and treatments for:
Hematologist Ruben Mesa, M.D., of Mayo Clinic in Arizona, provides a comprehensive overview of Essential Thrombocythemia, also known as ET. Dr. Mesa describes the fundamentals of this Myeloproliferative disease, covering symptoms and how it is diagnosed to current and potential future treatment options.
Polycythemia Vera (PV) is a disease that is part of a family of Myeloproliferative Neoplasm Disorders. This condition afflicts the bone marrow, causing an over production of cells. In the following video, Ruben Mesa, M.D., a hematologist at Mayo Clinic in Arizona, goes into an in-depth discussion on the disease covering its symptoms, diagnosis and treatment.
In this latest installment of his video series on Myeloproliferative Neoplasm Disorders, Dr Ruben Mesa, a hematologist at the Mayo Clinic in Arizona, provides an overview on Myelofibrosis. Learn about symtoms and treatment options associated with this condition.
In the next part of his Myeloproliferative Neoplasm Disorders video series, hematologist Ruben Mesa, M.D., of Mayo Clinic in Arizona, discusses treatment of Chronic Myeloid Leukemia.
